12 Month Price Forecast For PTHL
Distance to PTHL Price Forecasts
PTHL Price Momentum
๐ค Considering Pheton (PTHL)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 6, 2025 6:02 AM UTC
PTHL Analyst Ratings & Price Targets
Currently, there are no Wall Street analyst price targets or forecasts available for PTHL (Pheton).
PTHL is currently trading at $2.98. Without active analyst coverage, investors should conduct thorough independent research and consider multiple data points beyond price targets when evaluating this stock for their portfolio.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PTHL Analyst Consensus
PTHL Price Target Range
Latest PTHL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PTHL.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
Stocks Similar to Pheton Holdings Ltd Class A Ordinary Shares
The following stocks are similar to Pheton based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Pheton Holdings Ltd Class A Ordinary Shares (PTHL) Financial Data
Pheton Holdings Ltd Class A Ordinary Shares has a market capitalization of $63.09M with a P/E ratio of 0.0x. The company generates $572,291 in trailing twelve-month revenue with a -77.4% profit margin.
Revenue growth is -21.1% quarter-over-quarter, while maintaining an operating margin of -149.3% and return on equity of -188.2%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Pheton Holdings Ltd Class A Ordinary Shares (PTHL) Company Overview
About Pheton Holdings Ltd Class A Ordinary Shares
Develops healthcare solutions for brachytherapy.
The company generates revenue by developing and commercializing proprietary treatment software and devices that assist in brachytherapy, a form of radiation therapy used in cancer treatment. Their key product, the FTTPS, helps healthcare providers plan and execute treatment effectively, which enhances patient outcomes and drives demand for their solutions.
Founded in 1998 and based in Beijing, China, Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD, positioning itself in the growing healthcare technology sector focused on cancer treatment.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
11
CEO
Mr. Jianfei Zhang
Country
China
IPO Year
N/A
Website
www.ftzy.com.cnPheton Holdings Ltd Class A Ordinary Shares (PTHL) Latest News & Analysis
Pheton Holdings Ltd priced its IPO at $4.00 per share for 2.25 million shares, raising $9 million. Trading begins on Nasdaq under "PTHL" on September 5, 2024. Closing expected September 6, 2024.
Pheton Holdings' IPO at $4.00 per share raises $9 million, indicating market interest and potential growth in healthcare tech, particularly in cancer treatment, which could influence stock performance.
Pheton Holdings Ltd closed its IPO, offering 2,250,000 Class A shares at $4.00 each, raising $9 million before expenses.
Pheton Holdings' IPO raises $9 million, indicating investor confidence and potential for growth in the healthcare sector, particularly in specialized treatment technologies.
U.S. IPO Weekly Recap: 2 APAC Microcaps Go Public In Short Labor Day Week As The Pipeline Grows
4 months agoThis past week saw two small IPOs and two SPACs debut, with eight IPOs filing, including three targeting over $100 million. Two biotechs plan to raise $200 million each next Thursday.
The surge in IPO activity signals increased market confidence and capital availability, potentially leading to higher valuations and investment opportunities in various sectors.
Birkenstock led five IPOs this week, raising $1.5 billion at an $8.6 billion market cap. It is among the largest consumer discretionary IPOs in 20 years.
The successful IPOs, especially Birkenstock's, indicate strong market demand for consumer discretionary stocks, potentially boosting investor confidence and attracting more capital to the sector.
Pheton Holdings Pursues U.S. Micro-IPO
1 year agoPheton Holdings Ltd. has filed for an IPO aiming to raise $11.25 million. The company reports declining revenue, reduced gross profit, and an operating loss, with risks due to its small size.
Pheton Holdings' IPO plans highlight financial instability, with declining revenue and losses. Overvaluation and risks from its small size may deter investor confidence and affect stock performance.
Frequently Asked Questions About PTHL Stock
What is Pheton Holdings Ltd Class A Ordinary Shares's (PTHL) stock forecast for 2025?
Analyst forecasts for Pheton Holdings Ltd Class A Ordinary Shares (PTHL) are not currently available. The stock is trading at $2.98.
Is PTHL stock a good investment in 2025?
Analyst ratings for PTHL are not currently available. The stock is currently trading at $2.98. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for PTHL stock?
Price predictions from Wall Street analysts for PTHL are not currently available. The stock is trading at $2.98.
What is Pheton Holdings Ltd Class A Ordinary Shares's business model?
The company generates revenue by developing and commercializing proprietary treatment software and devices that assist in brachytherapy, a form of radiation therapy used in cancer treatment. Their key product, the FTTPS, helps healthcare providers plan and execute treatment effectively, which enhances patient outcomes and drives demand for their solutions.
What is the highest forecasted price for PTHL Pheton Holdings Ltd Class A Ordinary Shares?
Price targets from Wall Street analysts for PTHL are not currently available. The stock is trading at $2.98.
What is the lowest forecasted price for PTHL Pheton Holdings Ltd Class A Ordinary Shares?
Price targets from Wall Street analysts for PTHL are not currently available. The stock is trading at $2.98.
What is the overall PTHL consensus from analysts for Pheton Holdings Ltd Class A Ordinary Shares?
Analyst ratings for PTHL are not currently available. The stock is trading at $2.98.
How accurate are PTHL stock price projections?
Stock price projections, including those for Pheton Holdings Ltd Class A Ordinary Shares, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.